Kintayl Capital LP Makes New $2.23 Million Investment in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Kintayl Capital LP bought a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 200,000 shares of the pharmacy operator's stock, valued at approximately $2,234,000. Walgreens Boots Alliance accounts for about 1.6% of Kintayl Capital LP's holdings, making the stock its 23rd largest holding.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in Walgreens Boots Alliance by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator's stock valued at $805,506,000 after purchasing an additional 2,279,495 shares during the period. Invesco Ltd. lifted its position in shares of Walgreens Boots Alliance by 8.8% during the 4th quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator's stock valued at $303,902,000 after acquiring an additional 2,631,332 shares during the period. Geode Capital Management LLC lifted its position in shares of Walgreens Boots Alliance by 5.2% during the 4th quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator's stock valued at $194,082,000 after acquiring an additional 1,020,587 shares during the period. Northern Trust Corp lifted its position in shares of Walgreens Boots Alliance by 18.8% during the 4th quarter. Northern Trust Corp now owns 8,896,742 shares of the pharmacy operator's stock valued at $83,007,000 after acquiring an additional 1,407,973 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Walgreens Boots Alliance by 5.0% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,972,514 shares of the pharmacy operator's stock valued at $74,384,000 after acquiring an additional 378,039 shares during the period. Institutional investors and hedge funds own 58.59% of the company's stock.

Insiders Place Their Bets

In other Walgreens Boots Alliance news, Chairman Stefano Pessina acquired 832,258 shares of the company's stock in a transaction that occurred on Sunday, April 27th. The shares were purchased at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the completion of the purchase, the chairman directly owned 145,621,079 shares in the company, valued at $1,603,288,079.79. The trade was a 0.57% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 17.50% of the stock is currently owned by company insiders.

Walgreens Boots Alliance Stock Down 0.1%

Shares of Walgreens Boots Alliance stock traded down $0.02 during trading on Friday, reaching $11.50. The company had a trading volume of 1,616,695 shares, compared to its average volume of 19,061,080. The company has a market cap of $9.95 billion, a price-to-earnings ratio of -1.58, a price-to-earnings-growth ratio of 1.35 and a beta of 0.78. The firm's fifty day moving average is $11.35 and its 200-day moving average is $11.01. The company has a debt-to-equity ratio of 0.96, a quick ratio of 0.32 and a current ratio of 0.60. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $13.25.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.34 by $0.04. The business had revenue of $38.99 billion for the quarter, compared to analyst estimates of $36.72 billion. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The company's revenue for the quarter was up 7.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.63 EPS. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Morgan Stanley reiterated an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. UBS Group reissued a "neutral" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Finally, Wall Street Zen initiated coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, May 21st. They set a "hold" rating for the company. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, Walgreens Boots Alliance presently has a consensus rating of "Hold" and an average target price of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.